On or around 03/04/2019 (Ongoing date of last review)
Filing Date: March 01, 2019
According to the Complaint, Syneos purports to operate as an integrated biopharmaceutical solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America.
The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) Syneos Health’s internal control over financial reporting was inadequate; (2) concerns regarding Syneos Health’s internal control over financial reporting would result in heightened regulatory scrutiny and an SEC investigation into the company’s revenue accounting policies, internal controls and related matters; and (3) as a result, Defendants’ statements about Syneos Health’s business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis at all relevant times.
Company & Securities Information
Defendant: Syneos Health, Inc.
Industry: Biotechnology & Drugs
Headquarters: United States
Ticker Symbol: SYNH
Company Market: NASDAQ
Market Status: Public (Listed)
About the Company & Securities Data
"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.
In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
First Identified Complaint
Yuichi Murakami, et al. v. Syneos Health, Inc., et al.
COURT: D. New Jersey
DOCKET #: 19-CV-07377
JUDGE: Hon. Michael A. Shipp
DATE FILED: 03/01/2019
CLASS PERIOD START: 05/10/2017
CLASS PERIOD END: 02/27/2019
PLAINTIFF FIRMS NAMED IN COMPLAINT:
The Rosen Law Firm (South Orange) 609 W. South Orange Avenue Suite 2P , The Rosen Law Firm (South Orange), NJ 07079 (973) 313-1887 (973) 833-0399 ·
First Identified Complaint (FIC) Filings:
Class Action Complaint for Violations of the Federal Securities Laws
U.S. District Court Civil Docket
—Reference Complaint Complaint Related Data is not available
Related District Court Filings
—Related District Court Filings Data is not available